{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:19:23Z","timestamp":1789150763236,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.parkreldis.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T04:51:36Z","timestamp":1290574296000},"page":"46-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Masaaki","family":"Hirayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2010.11.004_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0014-5793(97)00523-1","article-title":"Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2\u2032-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment","volume":"409","author":"Erhola","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/10715760000301341","article-title":"The gastrointestinal tract: a major site of antioxidant action?","volume":"33","author":"Halliwell","year":"2000","journal-title":"Free Radic Res"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-5793(97)01273-8","article-title":"New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus","volume":"417","author":"Leinonen","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1212\/WNL.51.4.1014","article-title":"Oxidative damage to DNA in lymphocytes from AD patients","volume":"51","author":"Mecocci","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000154597.24838.6B","article-title":"Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease","volume":"64","author":"Sato","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson\u2019s disease","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","article-title":"Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra","volume":"69","author":"Alam","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/nbdi.2002.0466","article-title":"Systemic increase of oxidative nucleic acid damage in Parkinson\u2019s disease and multiple system atrophy","volume":"9","author":"Kikuchi","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000237221","article-title":"8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases","volume":"6","author":"Gmitterova","year":"2009","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1383-5718(98)00192-2","article-title":"8-Hydroxydeoxyguanosine in DNA from leukocytes of healthy adults: relationship with cigarette smoking, environmental tobacco smoke, alcohol and coffee consumption","volume":"439","author":"van Zeeland","year":"1999","journal-title":"Mutat Res"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0404.2007.00907.x","article-title":"Assessment of hallucinations in Parkinson\u2019s disease using a novel scale","volume":"117","author":"Wada-Isoe","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib13","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mds.22506","article-title":"Cognitive impairment in Parkinson\u2019s disease: tools for diagnosis and assessment","volume":"24","author":"Kulisevsky","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0024-3205(01)01124-9","article-title":"Increased oxidative stress in childhood atopic dermatitis","volume":"69","author":"Omata","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib16","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Prospective longitudinal assessment of hallucinations in Parkinson\u2019s disease","volume":"57","author":"Goetz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson\u2019s disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1353-8020(98)00022-4","article-title":"Mental dysfunction in Parkinson\u2019s disease","volume":"4","author":"Wolters","year":"1998","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib19","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/brain\/awp166","article-title":"Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson\u2019s disease","volume":"132","author":"Manganelli","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib20","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/mds.22258","article-title":"Brain response to complex visual stimuli in Parkinson\u2019s patients with hallucinations: a functional magnetic resonance imaging study","volume":"23","author":"Ramirez-Ruiz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib21","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/01.wnl.0000178896.44905.33","article-title":"ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies","volume":"65","author":"Devos","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib22","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/mds.22270","article-title":"Visual object recognition and attention in Parkinson\u2019s disease patients with visual hallucinations","volume":"23","author":"Meppelink","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib23","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1212\/WNL.63.8_suppl_3.S28","article-title":"Hallucinations and sleep disturbances in Parkinson\u2019s disease","volume":"63","author":"Kulisevsky","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2007.07.017","article-title":"Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson\u2019s disease","volume":"264","author":"Kitayama","year":"2008","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jns.2007.07.005","article-title":"Dobutamine stress test unmasks cardiac sympathetic denervation in Parkinson\u2019s disease","volume":"263","author":"Nakamura","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s004150050364","article-title":"Medication-induced hallucination and cerebral blood flow in Parkinson\u2019s disease","volume":"246","author":"Okada","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib27","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/mds.21140","article-title":"Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations","volume":"21","author":"Matsui","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2010.11.004_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp.2009.179655","article-title":"Differential progression of brain atrophy in Parkinson\u2019s disease with and without visual hallucinations","volume":"81","author":"Ibarretxe-Bilbao","year":"2010","journal-title":"J Neurol Neurosurg Psychiatr"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010002774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802010002774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:11:56Z","timestamp":1761178316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802010002774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1353802010002774"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2010.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}